Sat.Aug 10, 2024 - Fri.Aug 16, 2024

article thumbnail

STAT+: Medicare announces drug prices for historic first round of negotiations

STAT

WASHINGTON — The day drug makers dreaded has finally arrived.  Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them.  The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl

article thumbnail

Lessons from COVID: Tuskegee impacts still erode trust in healthcare, but hope shines through

PharmaVoice

A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.

240
240
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Not if, but when: Pandemic preparedness is crucial

pharmaphorum

On Wednesday, 14th August, the World Health Organization (WHO) announced the mpox outbreak in Africa as a public health emergency of international concern (PHEIC). By Thursday, 15th August, the first case of the severe variant was reported in Sweden, marking its emergence outside of Africa.

122
122
article thumbnail

Paul Rees: 'We have to keep pharmacy on the government's agenda'

The Pharmacist

The National Pharmacy Association (NPA) is ‘hopeful’ about the new government’s support for the sector, but is planning another day of action to keep pharmacy ‘on the agenda’. ‘The new government has had lots of issues to deal with in its first few weeks. We want to make sure that we remind the government this […] The post Paul Rees: 'We have to keep pharmacy on the government's agenda' appeared first on The Pharmacist.

119
119
article thumbnail

From Payroll Pains to Growth Gains: Streamlining Payroll & HR for Success

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

article thumbnail

As climate changes, scorching summers bring deadly heat for people with disabilities

STAT

Degree by degree, the earth’s temperature ticks up. Heat records fall as reliably as the sun sets. In July, the East Coast broiled. This week, Texas and its neighbors are feeling the burn. It’s been an absolute scorcher in the United States, the hottest summer on record. This summer might also be one of the coolest summers for the rest of your life.

363
363
article thumbnail

A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients

PharmaVoice

A series of executive turnovers at Gain Therapeutics this year precedes important early-stage Parkinson’s results that could change how the disease is treated.

189
189

More Trending

article thumbnail

October vaccination start could stretch pharmacy capacity, IPA warns

The Pharmacist

The October start date for Covid and flu vaccinations will cause 'problems with capacity' for community pharmacies as they juggle increased prescriptions and seasonal ailments alongside the vaccination programme, the chief executive of the Independent Pharmacies Association (IPA) has warned. This comes as NHS England (NHSE) confirmed this week that the main flu and Covid […] The post October vaccination start could stretch pharmacy capacity, IPA warns appeared first on The Pharmacist.

Vaccines 116
article thumbnail

WHO declares mpox outbreak a global health emergency

STAT

The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such declaration in the past two years called in response to transmission of the virus. The latest decision came on the recommendation of a panel of experts convened to advise WHO Director-General Tedros Adhanom Ghebreyesus on the issue.

364
364
article thumbnail

A potential MS ‘game changer’ could bring more safety to the table — even against viruses

PharmaVoice

Immunic’s treatment has anti-inflammation, neuroprotection and antiviral effects plus a ‘benign’ safety profile that even seems to lower the risk of COVID-19 infection.

article thumbnail

People need to know how to use AI now

pharmaphorum

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.

119
119
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Medicare reveals results of drug price negotiations

BioPharma Dive

The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.

article thumbnail

Opinion: Better safety studies could restore America’s confidence in vaccines

STAT

In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It proved to be a life-changing event: Two hours later as I was driving home, the shock of a sudden loud and high-pitched whistling nearly caused me to veer off the road. It was as if an audible dog whistle began blaring right next to me.

Vaccines 364
article thumbnail

Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.

PharmaVoice

The German biotech is leveraging its mRNA platforms to develop a new class of cancer treatments that are necessary to lift the company’s flagging sales.

147
147
article thumbnail

Longevity: Anti-ageing drugs, watch out, here we come…

pharmaphorum

Recent advancements in multi-omics, artificial intelligence (AI), deep learning (DL), ageing biomarkers, precision imaging, ageing clocks, robotics, and smart technologies have empowered researchers to pinpoint common pathways amenable to drug manipulation, with encouraging data now surfacing in early human clinical trials.

116
116
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot

BioPharma Dive

The vaccine didn’t spur a strong enough immune response against a particular flu strain in a Phase 3 trial, leading the companies to ponder adjustments.

article thumbnail

Three MDMA therapy papers retracted over data integrity concerns

STAT

The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels of the Food and Drug Administration’s rejection of the closely watched treatment for post-traumatic stress disorder. Many authors on the three studies are affiliated with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and its commercial spinout Lykos Therapeutics, including founder Rick Doblin, who spearheaded the decades-long efforts to win a

363
363
article thumbnail

M&A is ready to explode, and that’s good news for pharma layoffs

PharmaVoice

Deals driven by obesity meds are fueling an M&A comeback.

230
230
article thumbnail

Completing a successful tech transfer

pharmaphorum

CDMOs like Lannett play a critical role in tackling tech transfer challenges in the pharmaceutical industry. Learn how they navigate diverse challenges to ensure successful transfers.

115
115
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA approves first nasal spray for treatment of anaphylaxis

World Pharma News

The U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds). "Today's approval provides the first epinephrine product for the treatment of anaphylaxis that is not administered by injection.

108
108
article thumbnail

What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more

STAT

If you twirl a bottle of alcohol and squint, you might see a text box with a warning. Usually in black and white, with letters two to three millimeters high, it reads: GOVERNMENT WARNING: (1) According to the Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects. (2) Consumption of alcoholic beverages impairs your ability to drive a car or operate machinery, and may cause health problems.

Labelling 362
article thumbnail

The drugs hit hardest by Medicare price negotiations

PharmaVoice

The final negotiations slash drug prices between 38% and 79% for Medicare’s 2026 calendar year.

article thumbnail

The politics of health: How elections will impact life sciences

pharmaphorum

Explore how the recent and upcoming elections may impact the field of life sciences and medical technology. Stay informed about the intersection of politics and health advancements.

114
114
article thumbnail

Advice for young women in science - stay curious and inquisitive the rest will follow

Outsourcing Pharma

Katarina Wikstrom has worked for over 20 years in the field of translational molecular oncology and holds the position of VP global product development at Almac Diagnostic Services.

110
110
article thumbnail

Opinion: Ultra-processed foods: the tobacco of the 21st century?

STAT

At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, “Every new patient on my schedule is under 45.” She replied, “Three of mine are … this is too many young people with cancer.” We felt as though we were in the trenches and didn’t know where the bullets were coming from.

360
360
article thumbnail

Following FDA rejection, a journal retracts papers on MDMA-assisted therapy

BioPharma Dive

Editors at Psychopharmacology cited "unethical conduct" that the study authors didn't disclose when submitting the papers. Lykos Therapeutics says it filed a complaint with a third party to review the way the journal came to its decision.

111
111
article thumbnail

Advancing precision medicine: How real-world evidence platforms translate data into action

pharmaphorum

Learn how real-world evidence platforms use real-world data (RWD) to advance precision medicine, bridging the gap between clinical trials and real-world patient outcomes.

115
115
article thumbnail

Public health warning over rising rates of antibiotic-resistant gonorrhoea

The Pharmacist

Public health officials are warning of a concerning rise in antibiotic-resistant gonorrhoea infections in England. Data from the UK Health Security Agency shows there have been 15 new confirmed cases of ceftriaxone-resistant Neisseria gonorrhoeae between June 2022 and May 2024. This includes five cases which were extensively drug-resistant to first and second line antibiotics as well […] The post Public health warning over rising rates of antibiotic-resistant gonorrhoea appeared first on T

106
106
article thumbnail

To counter mpox, vaccine maker could ramp up by another 8 million doses next year

STAT

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply. This week’s declaration of a second public health emergency of international concern to deal with new and concerning outbreaks of mpox in Africa has again thrust the company onto cente

Vaccines 362
article thumbnail

Keeping Counterfeit Goods Out of the Supply Chain

Pharmaceutical Commerce

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, comments on other ways to limit ‘bad actors’ attempts to sneak counterfeit drugs into the supply chain, aside from the DSCSA.

105
105
article thumbnail

With FDA okay, AZ takes on MSD in early-stage lung cancer

pharmaphorum

AstraZeneca has claimed FDA approval for its immunotherapy Imfinzi before and after surgery for non-small cell lung cancer, setting up a contest with MSD's rival Keytruda.PD-L1 inhibitor Imfinzi (durvalumab) has been cleared for use in adult patients who need surgery for early-stage (IIA-IIIB) NSCLC and have no ALK or EGFR mutations that would make them suitable for targeted therapies.

110
110
article thumbnail

UKHSA updates mpox guidance for health professionals amid global health alert

The Pharmacist

The UK Health Security Agency (UKHSA) has updated its guidance to advise health professionals to be aware of a new more fatal variant of mpox, currently spreading in parts of central and East Africa. The UKHSA warning, issued today, comes after the World Health Organization (WHO) declared mpox a global public health emergency yesterday. There are […] The post UKHSA updates mpox guidance for health professionals amid global health alert appeared first on The Pharmacist.

105
105
article thumbnail

Opinion: Can AI help ease medicine’s empathy problem?

STAT

Modern medicine has an empathy problem. Artificial intelligence — done right — might be able to help ease it. Despite the proliferation of communication training programs over the past decade or two, doctors often fail to express empathy, especially in stressful moments when patients and their families are struggling to hear bad news and make difficult decisions.

article thumbnail

Lykos to cut 75% of staff after FDA rejection of MDMA-based therapy

BioPharma Dive

The layoffs are part of a larger reorganization that will also see the departure of Lykos’ founder, the psychedelics advocate Rick Doblin.

117
117